523 related articles for article (PubMed ID: 33464917)
1. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
[TBL] [Abstract][Full Text] [Related]
2. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
[TBL] [Abstract][Full Text] [Related]
4. Proteomics in the COVID-19 Battlefield: First Semester Check-Up.
Grenga L; Armengaud J
Proteomics; 2021 Jan; 21(1):e2000198. PubMed ID: 33236484
[TBL] [Abstract][Full Text] [Related]
5. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
Praissman JL; Wells L
Mol Cell Proteomics; 2021; 20():100103. PubMed ID: 34089862
[TBL] [Abstract][Full Text] [Related]
7. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
[TBL] [Abstract][Full Text] [Related]
8. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
[TBL] [Abstract][Full Text] [Related]
9. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.
Wang MY; Zhao R; Gao LJ; Gao XF; Wang DP; Cao JM
Front Cell Infect Microbiol; 2020; 10():587269. PubMed ID: 33324574
[TBL] [Abstract][Full Text] [Related]
11. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
Terracciano R; Preianò M; Fregola A; Pelaia C; Montalcini T; Savino R
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430309
[TBL] [Abstract][Full Text] [Related]
12. Cellular host factors for SARS-CoV-2 infection.
Baggen J; Vanstreels E; Jansen S; Daelemans D
Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A
Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346
[TBL] [Abstract][Full Text] [Related]
14. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
15. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.
Amiri-Dashatan N; Koushki M; Rezaei-Tavirani M
OMICS; 2022 Jan; 26(1):19-34. PubMed ID: 35005991
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
Selkrig J; Stanifer M; Mateus A; Mitosch K; Barrio-Hernandez I; Rettel M; Kim H; Voogdt CGP; Walch P; Kee C; Kurzawa N; Stein F; Potel C; Jarzab A; Kuster B; Bartenschlager R; Boulant S; Beltrao P; Typas A; Savitski MM
Mol Syst Biol; 2021 Feb; 17(2):e10188. PubMed ID: 33590968
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
[TBL] [Abstract][Full Text] [Related]
18. The Omic Insights on Unfolding Saga of COVID-19.
Kaur A; Chopra M; Bhushan M; Gupta S; Kumari P H; Sivagurunathan N; Shukla N; Rajagopal S; Bhalothia P; Sharma P; Naravula J; Suravajhala R; Gupta A; Abbasi BA; Goswami P; Singh H; Narang R; Polavarapu R; Medicherla KM; Valadi J; Kumar S A; Chaubey G; Singh KK; Bandapalli OR; Kavi Kishor PB; Suravajhala P
Front Immunol; 2021; 12():724914. PubMed ID: 34745097
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes.
Sirpilla O; Bauss J; Gupta R; Underwood A; Qutob D; Freeland T; Bupp C; Carcillo J; Hartog N; Rajasekaran S; Prokop JW
J Proteome Res; 2020 Nov; 19(11):4275-4290. PubMed ID: 32686937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
